• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征(PCOS)卵泡膜细胞中肌醇与手性肌醇(M/C)的比例降低,且M/C表异构酶活性增加,这表明与对照组相比,其胰岛素敏感性增强。

Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.

作者信息

Heimark Douglas, McAllister Jan, Larner Joseph

机构信息

Department of Pharmacology, University of Virginia, Charlottesville, VA 22903 USA.

出版信息

Endocr J. 2014;61(2):111-7. doi: 10.1507/endocrj.ej13-0423. Epub 2013 Nov 2.

DOI:10.1507/endocrj.ej13-0423
PMID:24189751
Abstract

Previous studies from our and other labs have shown that insulin resistance is associated with an inositol imbalance of excess myo-inositol and deficient chiro-inositol together with a deficiency of myo-inositol to chiro-inositol epimerase in vivo and in vitro. In this report, we utilized well characterized theca cells from normal cycling women, with normal insulin sensitivity, and theca cells from women with polycystic ovary syndrome (PCOS), with increased insulin sensitivity to examine the myo-inositol to chiro-inisitol (M/C) ratio and the myo-inositol to chiro-inositol epimerase activity. PCOS theca cells with increased insulin sensitivity were specifically used to investigate whether the inositol imbalance and myo-inositol to chiro-inositol epimerase are regulated in a similar or the opposite direction than that observed in insulin resistant cells. The results of these studies are the first to demonstrate that in insulin sensitive PCOS theca cells the inositol imbalance goes in the opposite direction to that observed in insulin resistant cells, and there is a decreased M/C ratio and an increased myo-inositol to chiro-inositol epimerase activity. Further biochemical and genetic studies will probe the mechanisms involved.

摘要

我们实验室和其他实验室之前的研究表明,胰岛素抵抗与肌醇失衡有关,即体内和体外均存在肌醇过量、手性肌醇缺乏以及肌醇向手性肌醇差向异构酶缺乏的情况。在本报告中,我们利用来自正常月经周期女性且胰岛素敏感性正常的特征明确的卵泡膜细胞,以及来自多囊卵巢综合征(PCOS)女性且胰岛素敏感性增加的卵泡膜细胞,来检测肌醇与手性肌醇(M/C)的比例以及肌醇向手性肌醇差向异构酶的活性。具有增加胰岛素敏感性的PCOS卵泡膜细胞被专门用于研究肌醇失衡和肌醇向手性肌醇差向异构酶是否与胰岛素抵抗细胞中的调节方向相似或相反。这些研究结果首次表明,在胰岛素敏感的PCOS卵泡膜细胞中,肌醇失衡与胰岛素抵抗细胞中的方向相反,M/C比例降低,肌醇向手性肌醇差向异构酶活性增加。进一步的生化和遗传学研究将探究其中涉及的机制。

相似文献

1
Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.多囊卵巢综合征(PCOS)卵泡膜细胞中肌醇与手性肌醇(M/C)的比例降低,且M/C表异构酶活性增加,这表明与对照组相比,其胰岛素敏感性增强。
Endocr J. 2014;61(2):111-7. doi: 10.1507/endocrj.ej13-0423. Epub 2013 Nov 2.
2
Inositols: From Established Knowledge to Novel Approaches.肌醇:从已有知识到新方法。
Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575.
3
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.多囊卵巢综合征高雄激素表型中肌醇的作用:重新解读拉纳的研究结果。
Int J Mol Sci. 2023 Mar 27;24(7):6296. doi: 10.3390/ijms24076296.
4
Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.与Wistar对照大鼠相比,GK 2型糖尿病大鼠组织中的肌醇向手性肌醇表异构酶活性以及手性肌醇与肌醇的比例均降低。
Biochem Biophys Res Commun. 2002 May 10;293(3):1092-8. doi: 10.1016/S0006-291X(02)00313-3.
5
The D-chiro-inositol paradox in the ovary.卵巢中的 D-手性肌醇悖论。
Fertil Steril. 2011 Jun 30;95(8):2515-6. doi: 10.1016/j.fertnstert.2011.05.027. Epub 2011 Jun 8.
6
Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.多囊卵巢综合征女性中D-手性肌醇尿清除率的改变
Diabetes Care. 2006 Feb;29(2):300-5. doi: 10.2337/diacare.29.02.06.dc05-1070.
7
Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.多囊卵巢综合征中的肌醇:基于病理生理学的方法恢复生育能力。
Trends Endocrinol Metab. 2018 Nov;29(11):768-780. doi: 10.1016/j.tem.2018.09.001. Epub 2018 Sep 27.
8
Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.用 D-手性肌醇和α-硫辛酸治疗多囊卵巢综合征。
Gynecol Endocrinol. 2019 Jun;35(6):506-510. doi: 10.1080/09513590.2018.1540573. Epub 2019 Jan 7.
9
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.多囊卵巢综合征患者肌醇和 D-手性肌醇对卵巢功能和代谢因素影响的比较。
Gynecol Endocrinol. 2014 Mar;30(3):205-8. doi: 10.3109/09513590.2013.860120. Epub 2013 Dec 19.
10
Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS.多囊卵巢综合征中病理性甾体生成的原因可能是卵巢肌醇比值改变。
Int J Mol Sci. 2020 Sep 28;21(19):7157. doi: 10.3390/ijms21197157.

引用本文的文献

1
Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial.补充肌醇预防多囊卵巢综合征妊娠并发症:一项随机临床试验。
JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.13668.
2
Antioxidant and cytokine modulation in PCOS rats protected with probiotics, myo-inositol, and herbal extracts.益生菌、肌醇和草药提取物对多囊卵巢综合征大鼠抗氧化及细胞因子的调节作用。
Vet Med (Praha). 2025 Jun 27;70(6):203-217. doi: 10.17221/116/2024-VETMED. eCollection 2025 Jun.
3
PCOS and Inositols - Advances and Lessons We are Learning. A Narrative Review.
多囊卵巢综合征与肌醇——我们正在汲取的进展与经验。一篇叙述性综述。
Drug Des Devel Ther. 2025 May 21;19:4183-4199. doi: 10.2147/DDDT.S524718. eCollection 2025.
4
Diagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review.青少年多囊卵巢综合征的诊断与治疗:综述
Int J Womens Health. 2025 Feb 19;17:459-474. doi: 10.2147/IJWH.S506498. eCollection 2025.
5
Inositol Restores Appropriate Steroidogenesis in PCOS Ovaries Both In Vitro and In Vivo Experimental Mouse Models.肌醇可恢复多囊卵巢综合征卵巢的适当类固醇生成,无论是在体外还是体内实验性小鼠模型中。
Cells. 2024 Jul 9;13(14):1171. doi: 10.3390/cells13141171.
6
Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women's Endocrinology.肌醇与女性生殖障碍:意大利内分泌学会(SIE)-女性内分泌学工作组的共识声明。
J Endocrinol Invest. 2024 Sep;47(9):2111-2141. doi: 10.1007/s40618-024-02363-w. Epub 2024 Jul 15.
7
Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports.采用专利的3.6:1肌醇与D-手性肌醇比例、抗氧化剂、维生素和矿物质的食品补充剂治疗有辅助生殖技术(ART)失败史的女性:一系列病例报告。
Clin Med Insights Case Rep. 2024 Mar 29;17:11795476241242265. doi: 10.1177/11795476241242265. eCollection 2024.
8
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.40:1 配比的肌醇和 D-手性肌醇对按照 Rotterdam 标准分类为表型 A 及按照 EGOI 标准分类为 EMS 类型 1 的多囊卵巢综合征女性的激素和代谢特征的影响。
Gynecol Obstet Invest. 2024;89(2):131-139. doi: 10.1159/000536163. Epub 2024 Jan 31.
9
Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes.肌醇治疗并不能改善所有多囊卵巢综合征表型的临床特征。
Biomedicines. 2023 Jun 19;11(6):1759. doi: 10.3390/biomedicines11061759.
10
Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review.肌醇和 D-手性肌醇作为卵巢甾体激素生成的调节剂:叙述性综述。
Nutrients. 2023 Apr 13;15(8):1875. doi: 10.3390/nu15081875.